Neue Therapieoption für das fortgeschrittene HER2-positive MammakarzinomNew treatment options for advanced HER2-positive breast cancer

被引：0
|
作者：
D. Forstmeyer
机构：
[1] Universitätsklinikum Leipzig,Universitäres Krebszentrum Leipzig (UCCL)
来源：
Der Onkologe | 2013年 / 19卷 / 1期
关键词：
D O I：
10.1007/s00761-012-2375-y
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：60 / 61
页数：1
相关论文
共 50 条
  • [21] HER2-directed therapy: current treatment options for HER2-positive breast cancer
    Ahmed, Shahid
    Sami, Amer
    Xiang, Jim
    BREAST CANCER, 2015, 22 (02) : 101 - 116
  • [22] The Adjuvant Treatment of HER2-Positive Breast Cancer
    Jelovac, Danijela
    Wolff, Antonio C.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2012, 13 (02) : 230 - 239
  • [23] Treatment strategy for HER2-positive breast cancer
    Hirofumi Mukai
    International Journal of Clinical Oncology, 2010, 15 : 335 - 340
  • [24] INDIVIDUALIZED TREATMENT FOR HER2-POSITIVE BREAST CANCER
    Takano, Toshimi
    ANNALS OF ONCOLOGY, 2014, 25
  • [25] HER2-directed therapy: current treatment options for HER2-positive breast cancer
    Shahid Ahmed
    Amer Sami
    Jim Xiang
    Breast Cancer, 2015, 22 : 101 - 116
  • [26] Beyond trastuzumab: New treatment options for HER2-positive breast cancer
    Saini, Kamal S.
    Azim, Hatem A., Jr.
    Metzger-Filho, Otto
    Loi, Sherene
    Sotiriou, Christos
    de Azambuja, Evandro
    Piccart, Martine
    BREAST, 2011, 20 : S20 - S27
  • [27] Systemic Therapies for HER2-Positive Advanced Breast Cancer
    Angelis, Vasileios
    Okines, Alicia F. C.
    CANCERS, 2024, 16 (01)
  • [28] Two Drugs for Advanced HER2-Positive Breast Cancer
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2020, 62 (1611): : 182 - 184
  • [29] Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
    Verma, Sunil
    Miles, David
    Gianni, Luca
    Krop, Ian E.
    Welslau, Manfred
    Baselga, Jose
    Pegram, Mark
    Oh, Do-Youn
    Dieras, Veronique
    Guardino, Ellie
    Fang, Liang
    Lu, Michael W.
    Olsen, Steven
    Blackwell, Kim
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (19): : 1783 - 1791
  • [30] Inflammatory HER2-positive breast cancer
    Dirix, Luc Y.
    Vermeulen, Peter B.
    LANCET ONCOLOGY, 2012, 13 (04): : 324 - 326
12345